AVE 50.0% 0.3¢ avecho biotechnology limited

Ann: March 2024 Quarterly Activities Report & Appendix 4C, page-55

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,181 Posts.
    lightbulb Created with Sketch. 68
    Well flec' it's hardly pointless because tpm has shown no superiority to many of the existing array of permeators and solubilizers . This may no doubt explain its lack of commercial success over two decades .
    If indeed a high absorption of cbd does mitigate insomnia I can't see any reason why Pharma would choose tpm . There's a plethora of research on the solubilty and absorption of other compounds readily available and substantially more cost effective.
    Can you show me anything in the literature validating tpm/cbd absorption ?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(50.0%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.3¢ 0.2¢ $374 177.9K

Buyers (Bids)

No. Vol. Price($)
17 13775201 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 41099031 27
View Market Depth
Last trade - 11.34am 06/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.